Researchers turn to familiar model animals, along with some fresh strategies, to develop countermeasures against SARS-CoV-2 and investigate the biology of infection.

The cholesterol-lowering drugs quell inflammation and reverse endothelial tissue damage, hints that they might curb the body’s excessive immune response to SARS-CoV-2 infection.

In mice, a group of nasal epithelial cells called brush cells release pro-inflammatory signals in response to allergens.

Scientists identify the cells that give rise to the soft tissue cancer rhabdomyosarcoma.